Rubiadin

Rubiadin

SCHEMBL1426928

Cc1c(O)cc2c(c1O)C(=O)c1ccccc1C2=O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 4/20 0.71
MCL1 Q07820 4/20 0.71
ELANE P08246 1/20 0.59
MAPT P10636 5/20 0.58
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
MAOA P21397 3/20 0.58
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
CYP3A4 P08684 2/20 0.58
HPGD P15428 2/20 0.58
ALOX15 P16050 2/20 0.58
ALOX12 P18054 2/20 0.58
MAPK1 P28482 2/20 0.58
RECQL P46063 2/20 0.58
DAPK1 P53355 2/20 0.58
CYP1B1 Q16678 2/20 0.58
HSD17B10 Q99714 2/20 0.58
APEX1 P27695 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rubiadin SCHEMBL30260037 1.00 BCL2 (0.71) BCL2MCL1ELANEMAPTMEN1
Rubiadin SCHEMBL22616292 1.00 BCL2 (0.71) BCL2MCL1ELANEMAPTMEN1
Rubiadin SCHEMBL29665059 1.00 BCL2 (0.71) BCL2MCL1ELANEMAPTMEN1
SCHEMBL28690510 0.86 MAOA (0.63) BCL2MCL1ELANEMAPTMEN1
SCHEMBL3174840 0.86 BCL2 (0.71) BCL2MCL1ELANEMAPTMEN1
SCHEMBL22719980 0.85 TTR (0.66) BCL2MCL1ELANEMAPTMEN1
SCHEMBL31237387 0.85 TTR (0.66) BCL2MCL1ELANEMAPTMEN1
SCHEMBL23198971 0.84 MEN1 (0.58) BCL2MCL1ELANEMAPTMEN1
SCHEMBL17867446 0.83 BCL2 (0.61) BCL2MCL1ELANEMAPTMEN1
SCHEMBL555230 0.83 BCL2 (1.00) BCL2MCL1ELANEMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4674429-A1 COMPOSIZIONE PER IL TRATTAMENTO DELL'EDEMA E DEL LINFEDEMA Anvest Group S.r.l. (IT) 2026-01-07 EP claimed
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
US-11896709-B2 Natural vegetable source based hair colour GODREJ CONSUMER PRODUCTS LTD. (IN) 2024-02-13 US claimed
US-20230270662-A1 NATURAL VEGETABLE SOURCE BASED HAIR COLOUR GODREJ CONSUMER PRODUCTS LTD. (IN) 2023-08-31 US claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
CN-115245533-B Application of Nanshan flower root extract in treating pulmonary fibrosis 中国医学科学院药物研究所 2023-07-28 CN claimed
CN-111925405-B Methylisopyrazine A ring glycosylation derivative and preparation method and application thereof 湖南省人民医院 2023-03-28 CN claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
CN-115607589-A Application of gentiana macrophylla and monomer compound thereof in mite killing 珠海岐微生物科技有限公司 2023-01-17 CN claimed
CN-115304619-A Crystal form of rubitinid and preparation method thereof 上海皓元医药股份有限公司 2022-11-08 CN claimed
EP-2018142-A2 COMPOSITION FOR DYEING KERATIN FIBERS AND A METHOD OF DYEING HAIR USING SAME Advance Cosmetic Technologies LLC (US) 2009-01-28 EP claimed
WO-2007130777-A2 COMPOSITION FOR DYEING KERATIN FIBERS AND A METHOD OF DYEING HAIR USING SAME ADVANCED COSMETIC TECHNOLOGIES LLC (US) 2007-11-15 WO claimed
US-20070251024-A1 COMPOSITION FOR DYEING KERATIN FIBERS AND A METHOD OF DYEING HAIR USING SAME ADVANCED COSMETIC TECHNOLOGIES, LLC 2007-11-01 US claimed
US-20030082101-A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species CAVALIER DISCOVERY 2003-05-01 US claimed
WO-2002100478-A9 ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES CAVALIER DISCOVERY (US) 2003-03-27 WO claimed
WO-2002100478-A2 ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES CAVALIER DISCOVERY (US) 2002-12-19 WO claimed
EP-0496349-B1 Coating solution for preventing adhesion of polymer scale and method for its use SHINETSU CHEMICAL CO (JP) 1996-04-10 EP claimed
US-5241022-A Polyvinyl alcohol with saponification of not less than seventy percent and quinone SHIN-ETSU CHEMICAL CO., LTD. (JP) 1993-08-31 US claimed
EP-0496349-A1 Coating solution for preventing adhesion of polymer scale and method for its use SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-07-29 EP claimed
US-4602913-A Use of hydroxyanthraquinones for the coloration of human keratin fibres L'OREAL (FR) 1986-07-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082101-A1 Accelerators for increasing the rate of formation of free radicals and reactive oxygen species SOD1, SOD3, APEX1 BCL2 410/4885MCL1 347/4885ELANE 1326/4885
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES FABP2, FABP4, GUSB BCL2 646/4885MCL1 2223/4885ELANE 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.